Introduction
Iron±sulfur (Fe±S) clusters are abundant and pervasive cofactors that are essential for a wide variety of processes, including facilitation of electron transfer processes in oxidative phosphorylation, catalysis of enzymatic reactions in aconitase and dehydratases, and maintenance of structural integrity in the DNA repair enzyme endonuclease III (Beinert and Holm, 1997) . In addition, Fe±S clusters are critical in enabling cells to sense intracellular iron and/or oxidant levels, as in the case of iron regulatory protein 1 (IRP1), a sensor of intracellular iron levels, and the bacterial proteins SoxR and FNR, sensors of intracellular oxygen species (Rouault and Klausner, 1996; Beinert and Kiley, 1999) . Over the last few decades, much has been learned about the structure and function of Fe±S clusters, but, until recently, little was known about the in vivo cluster assembly process.
Enzymes involved in Fe±S cluster assembly were ®rst identi®ed within the nif (nitrogen ®xation) operon, which encodes proteins critical in the biosynthesis of functional nitrogenase in the nitrogen-®xing bacterium Azotobacter vinelandii. Genetic studies in these bacteria showed that disruption of two of the open reading frames (ORFs) in the nif operon, nifS or nifU, resulted in loss of nitrogenase activity (Jacobson et al., 1989) . Although nitrogenase polypeptides were synthesized, the Fe±S clusters essential for activity were absent, implicating nifS and nifU in the process of Fe±S cluster assembly. More recently, homologs of nifS and nifU have been identi®ed in non-nitrogen®xing organisms, including Escherichia coli, yeast and higher eukaryotes, leading to the proposal that these genes are involved in the general process of Fe±S cluster assembly (Zheng et al., 1998) . Biochemical studies have demonstrated that NifS and its homologs mobilize inorganic sul®de (Zheng et al., 1993) , and NifU homologs bind [2Fe±2S] clusters (Fu et al., 1994) . Hence, they have been designated as isc genes to indicate their proposed roles in iron±sulfur cluster assembly (Zheng et al., 1998) .
Within the last 2 years, several yeast proteins with high homology to bacterial nifU have been identi®ed and revealed to have unexpected importance in mitochondrial iron homeostasis and function. Isu1 and Isu2 are two distinct genes in Saccharomyces cerevisiae that encode protein homologs of the N-terminal domain of bacterial NifU (Garland et al., 1999) , whereas Nfu1 is an S.cerevisiae homolog of the C-terminal domain of bacterial NifU (Schilke et al., 1999) . Genetic studies have demonstrated that these gene products are essential in S.cerevisiae, as yeast strains harboring deletions in both isu1 and isu2 loci (Disu1Disu2) are inviable. Activities of several mitochondrial Fe±S proteins decrease in Disu1, Disu2 or Disu1Dnfu1 mutant strains, consistent with the proposal that these NifU homologs function in Fe±S cluster assembly in yeast mitochondria (Garland et al., 1999; Schilke et al., 1999) . In strains that express an activated allele of the iron-sensing transcription factor, Aft1, expression of isu1 and isu2 increases, indicating that these genes are regulated by the iron status of the cell (Garland et al., 1999) . Signi®cant mitochondrial iron accumulation occurs in Disu1, Disu2 or Disu1Dnfu1 strains (Garland et al., 1999; Schilke et al., 1999) , implying that NifU homologs play an important role not only in Fe±S cluster synthesis, but also in maintenance of normal mitochondrial iron homeostasis. While extensive studies have revealed much about iron uptake, storage and regulation in the yeast cytosol (Askwith and Kaplan, 1998) , much remains to be learned about mitochondrial iron homeostasis. Elucidation of the function of isc genes in mitochondria should lead to better understanding of iron homeostasis in mitochondria.
The complexity and importance of mitochondrial iron metabolism are underscored by recent studies that indicate a link between mitochondrial iron homeostasis and the neurodegenerative disease Friedreich's ataxia. Frataxin, the disease gene in Friedreich's ataxia (Campuzano et al., 1996) , is a mitochondrial protein required for maintenance Distinct iron±sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells The EMBO Journal Vol. 19 No. 21 pp. 5692±5700, 2000 of normal mitochondrial iron levels (Babcock et al., 1997; Radisky et al., 1999) . In the absence of functional frataxin, iron accumulates in mitochondria, causing oxidative damage to mitochondrial DNA and various mitochondrial Fe±S proteins.
In addition to understanding Fe±S protein biosynthesis in the mitochondria, another important aim in pursuing studies of Fe±S cluster assembly is to understand the molecular basis for regulation of the mammalian cytosolic iron-sensing protein IRP1. IRP1 and IRP2 are proteins that regulate expression of numerous iron metabolism proteins, including ferritin and transferrin receptor, to ensure that uptake and sequestration of iron are appropriate to cellular needs. In iron-replete cells, IRP1 contains a [4Fe±4S] cluster and is a functional aconitase, interconverting citrate and isocitrate in the cytosol. In cells that are depleted of iron, IRP1 lacks the Fe±S cluster, and the apoprotein binds RNA stem±loop sequences known as iron-responsive elements (IREs) that are found in transcripts of several iron metabolism proteins. The position of the IRE in the transcript determines whether IRP binding will inhibit translation of transcripts such as ferritin, or mRNA turnover in transcripts such as transferrin receptor (reviewed in Hentze and Kuhn, 1996; Rouault and Klausner, 1997) . Since the Fe±S cluster is the key to IRP1 function, it is of great interest to understand how Fe±S clusters are assembled.
To understand fully the regulation of the cytosolic protein IRP1, and to understand iron metabolism in mitochondria, we have cloned and characterized the human homolog of NifU. Our results indicate that alternative splice products encode distinct isoforms that are targeted to the mitochondria, the cytosol and the nucleus. Furthermore, human IscU proteins are speci®c-ally associated with distinct forms of human IscS proteins in different subcellular compartments, indicating that Fe±S cluster assembly is compartmentalized in mammalian cells.
Results

Cloning of human iscU homolog
The human expressed sequence tag (EST) database was searched, and analysis of multiple ESTs revealed that there are two ORFs that show high homology to yeast Isu1 and Isu2 ( Figure 1A ). The complete cDNA sequences were derived from sequencing of EST clones and 5¢ RACE (rapid ampli®cation of cDNA ends) products. Sequencing analysis revealed that these two cDNAs are identical in most of the coding region and the 3¢ UTR, differing only in the 5¢ UTRs and the beginning of the coding sequences. IscU1 mRNA was predicted to encode a protein with a 13 amino acid N-terminal sequence unique to IscU1. Conversely, iscU2 was predicted to encode a protein with a 39 amino acid N-terminal sequence unique to IscU2.
A genomic fragment that contained the 5¢ end of iscU was cloned, and mapping of the intron±exon boundaries suggested that alternative splicing could result in generation of the two different isoforms. As shown in Figure 1B , exon IA contains the N-terminal sequence information included in the IscU2 mRNA sequence, whereas exon IB contains the N-terminal sequence information included in the IscU1 mRNA sequence. To assess whether alternative transcription initiation sites were used, the 5¢ cDNA ends of iscU were synthesized from human heart (or liver) poly(A) + RNA and ampli®ed by nested PCR. Sequencing analysis indicated that both the iscU1 and iscU2 mRNAs shared the same transcription initiation site. They differed in that iscU2 mRNA contained exon IA but not exon IB (Figure 2A ), whereas iscU1 mRNA contained both exon IA and exon IB. However, in the iscU1 transcript, initiation at AUG1 would result in synthesis of a short upstream ORF due to termination at an in-frame stop codon present in exon IB. Synthesis of functional IscU1 protein would instead initiate at AUG2. Taken together, these 5¢ RACE experiments indicated that IscU1 and IscU2 share a common pre-mRNA and are encoded by alternatively spliced transcripts.
A separate set of nested PCR experiments also con®rmed alternative splicing of human iscU. As shown in Figure 2B , nested PCR of the 5¢ RACE products using a primer within exon IA and a primer within exon III generated a 240 bp product that contained exon IA but not exon IB, as expected from the IscU2 mRNA sequence. PCR using a primer within exon IB and a primer within exon III generated the 200 bp product as predicted from the mRNA sequence for IscU1 ( Figure 2B ). In addition, this reaction also ampli®ed several fragments of higher molecular weight ( Figure 2B , middle panel). Southern hybridization using intron IB as a probe indicated that these bands represented partially spliced intermediates ( Figure 2B , right panel), the sizes of which are consistent with predicted splicing intermediates based on genomic DNA sequence. Northern blot analyses performed with probes speci®c to each 5¢ end indicated that endogenous iscU2 mRNA is~1.3 kb and iscU1 mRNA is~1.4 kb ( Figure 2C ), sizes that are consistent with the cDNA data. Although the sizes of these mRNAs are similar, the size difference is discernible in northern blots ( Figure 2C ). Furthermore, two lines of evidence indicate that these two bands represent two different IscU transcripts. First, experiments shown in Figure 2B indicate that the Fig. 2 . Alternative splicing of iscU pre-mRNA results in two isoforms with different predicted N-terminal sequences. (A) Schematic representation of iscU1 and iscU2 5¢ cDNA ends. Nested PCR of a 5¢ RACE fragment was carried out using a cap-binding primer, in combination with iscU genespeci®c primers. Sequence analysis indicated that iscU1 and iscU2 are alternative splice products. (B) Nested PCR of a 5¢ RACE fragment was carried out using a 3¢ primer within exon III in combination with 5¢ primers speci®c to either exon IA or exon IB. Southern blot analysis was carried out using exon IA, exon IB or intron IB probe. Arrowheads denote bands of the appropriate sizes as expected from iscU1 and iscU2 mRNA sequences. Asterisks denote bands containing intron sequence and are derived from splicing intermediates. (C) Northern blot analysis of poly(A) + RNA from RD4 cells and human heart (Clontech) was carried out using exon IA, exon IB or intron IB probe. Arrowheads denote bands of the appropriate sizes as expected from iscU1 and iscU2 mRNA sequences. Asterisks denote splicing intermediates. (D) Human multiple tissue northern blotting (Clontech) revealed that iscU, iscS and iscA are all expressed predominantly in heart and skeletal muscle.
exon IA and exon IB probes are very speci®c and that there are no discernible cross-reactions. Secondly, the 1.3 kb band observed using exon IA as a probe is clearly stronger in human heart mRNA than in RD4 mRNA, whereas the 1.4 kb band observed using exon IB as a probe is weaker in human heart mRNA than in RD4 mRNA. These results provide additional evidence that the two probes are hybridizing with different transcripts. In a human multiple tissue northern blot (Clontech) probed with sequences common to both cDNAs, the~1.35 kb band detected predominantly in heart and skeletal muscle ( Figure 2D ) is likely to arise from overlap of signals from the two cDNAs.
In summary, the iscU1 cDNA comprises 1090 bp and contains an ORF encoding a protein of 142 amino acids with a predicted molecular mass of 15.4 kDa. The iscU2 cDNA comprises 990 bp and contains an ORF encoding a protein of 168 amino acids with a predicted molecular mass of 17.9 kDa.
Transiently expressed IscU1 and IscU2 are targeted to different subcellular compartments Analysis of the two different N-terminal sequences of human IscU1 and IscU2 suggested that these two proteins might be targeted to different subcellular locations. Sorting programs identi®ed the N-terminal sequence of IscU2 as a putative mitochondrial targeting sequence, whereas IscU1 was predicted to be a cytosolic protein (Nakai and Kanehisa, 1992) . The expression and localization of IscU1 and IscU2 were examined by immuno¯uorescence microscopy in COS cells that were transfected with expression constructs containing the two different ORFs (Figure 3 ). In cells transfected with the IscU1 construct, staining was detected in the cytosol and the nucleus. In contrast, the IscU2 proteins were detected in the mitochondria, as judged by co-localization with the mitochondrial marker rhodamine 123.
Transient expression of IscU2 in COS cells also revealed that the IscU2 translation product underwent a rapid, two-step processing into a shorter cleavage product of~15 kDa ( Figure 4B ), consistent with proteolytic removal of the N-terminal targeting sequence upon import into the mitochondrial matrix (Pfanner et al., 1997) . Comparison with the consensus sequence for mitochondrial matrix processing sites suggested that proteolytic cleavages would occur initially at E27 and subsequently at Y35. To verify this hypothesis, we analyzed the in vitro translation product from a construct in which the N-terminal sequence up to Y35 was deleted. The IscU2D35 co-migrated with the fully processed IscU2 in transfected COS cells, thus supporting the conclusion that IscU2 is cleaved at or near Y35 upon import into mitochondria ( Figure 4B ). In addition, the in vitro translation product of IscU2D27, a construct from which the ®rst 27 amino acids of IscU2 were deleted, co-migrated with the processing intermediate identi®ed in transfected COS cells in Figure 4 (data not shown). 
Compartmentalization of iron±sulfur cluster assembly
Subcellular localization of endogenous IscU proteins
To analyze the endogenous IscU proteins, antibodies were raised against two different peptides within the region common to both isoforms. Metabolic labeling and immunoprecipitation experiments indicated that both antibodies 2677 and 2934 immunoprecipitated a 14 kDa protein (p14) from RD4 cell lysates, strongly suggesting that this is an endogenous IscU protein ( Figure 5A ). In addition, a weaker p15 protein was also identi®ed in immunoprecipitations using one of the antibodies (a-IscU 2934). Comparison with recombinant IscU proteins expressed in E.coli indicated that p14 co-migrated with IscU2D35, whereas p15 co-migrated with IscU1 ( Figure 5A ). These results suggested that p14 is the processed form of mitochondrial IscU2, whereas p15 is a form of IscU1.
The subcellular localizations of endogenous IscU proteins were further assessed by fractionation experiments. Immunoprecipitation experiments ( Figure 5B ) and western blot analyses ( Figure 5C ) using two different antibodies showed that p14 is the sole form of IscU in the membrane organelle fraction, whereas p15 is detected in the cytosolic fraction. Taken together, these results support the hypothesis that IscU2 is a mitochondrial form of IscU, whereas IscU1 is a cytosolic isoform.
In addition to p14 and p15, experiments shown in Figure 5 also identify a 19 kDa protein (p19) as another form of cytosolic IscU. As shown in Figure 5A , p19 was immunoprecipitated with two a-IscU antibodies that bind to different regions of the antigen, consistent with the possibility that p19 is also an endogenous IscU. Subcellular fractionation experiments ( Figure 5B ) and western blot analysis ( Figure 5C ) indicated that p19 is present in the cytosolic fraction, suggesting that p19 represents either a cytosolic precursor of mitochondrial IscU2 or a modi®ed form of cytosolic IscU1. It is not yet clear why a form of cytosolic IscU1 migrates as a 19 kDa band. Unusual behavior on SDS±PAGE has previously been reported for another putative Fe±S cluster assembly protein in A.vinelandii: ferredoxin IV (FdIV) (Jung et al., 1999a) . Although mass spectrometry data indicated that native FdIV apoprotein had a mass of 12.43 kDa and recombinant FdIV apoprotein had a mass of 12.48 kDa, SDS±PAGE indicated that native FdIV apoprotein migrated as a 25 kDa band while recombinant FdIV apoprotein migrated as a 14 kDa band (Jung et al., 1999a) . Likewise, A.vinelandii ferredoxin I (FdI) has a mass of 12 kDa, but migrated as a 24 kDa band (Jung et al., 1999b) . These results suggest that a small modi®cation of low molecular weight Fe±S proteins like IscU, FdI or FdIV can result in anomalous behavior on SDS±PAGE.
Co-immunoprecipitation of IscU with IscS in RD4 cells
Since previous studies have shown that different forms of human IscS proteins localize to the mitochondria, the cytosol and the nucleus (Land and Rouault, 1998) , we addressed the possibility that there are distinct Fe±S cluster assembly complexes in different subcellular compartments. In these`immunoprecipitation±recapture' experiments, IscU and its associated proteins were ®rst immunoprecipitated with a-IscU from RD4 Triton lysate. Immunoprecipitates were denatured by treatment with SDS±dithiothreitol (DTT) and heat, and a second immunoprecipitation (recapture) was carried out with a-IscS. Only the 47 kDa mitochondrial form of IscS was detected in association with IscU in RD4 lysate ( Figure 6A) , consistent with the observation that there is much more precipitable mitochondrial IscU than cytosolic IscU ( Figure 5) .
To enhance the probability of detecting speci®c cytosolic complexes, co-immunoprecipitations were performed on fractionated lysates. IscU and its associated proteins were ®rst immunoprecipitated with a-IscU from the cytosolic or the membrane organelle fraction of RD4 cells. A 45 kDa protein was recaptured by IscS antibodies from the cytosolic fraction, whereas a 47 kDa band was recaptured in the membrane organelle fraction ( Figure 6B ). These IscS bands co-migrated with bands that have been previously shown to represent cytosolic and mitochondrial forms of IscS, respectively (Land and Rouault, 1998) , clearly indicating that separate Fe±S cluster assembly complexes are present in the cytosol and in the mitochondria.
Discussion
Iron±sulfur cluster assembly in mammalian cells
In the last few years, elegant work in bacteria has revealed that the assembly of Fe±S clusters is mediated by a number of proteins, including enzymes that generate inorganic sulfur, enzymes that incorporate iron into rudimentary clusters and chaperone molecules that direct the unfolding of the recipient proteins (Zheng et al., 1993 (Zheng et al., , 1998 Agar et al., 2000; Yuvaniyama et al., 2000) . The tasks of assembly and insertion of clusters into appropriate recipient proteins are complex in mammalian cells, in part because proteins that require Fe±S clusters for function are found not only in the mitochondria, but also in the cytosol. In addition, mammalian cells may have mechanisms that allow discrimination amongst potential recipients of Fe±S clusters. Mammalian zinc ®nger proteins are known to acquire Fe±S clusters sometimes when overexpressed in bacteria (Li et al., 1991; Archer et al., 1994) , but Fe±S clusters are not inappropriately inserted into zinc ®nger proteins in mammalian cells.
To gain understanding of the process of Fe±S cluster assembly in mammalian cells, we have undertaken systematic cloning of mammalian homologs of bacterial isc proteins. Previously, we have cloned and characterized the human homolog of bacterial NifS and demonstrated that an unusual type of translational regulation involving alternative utilization of in-frame AUGs allows synthesis of IscS proteins that are targeted either to mitochondria or to cytosol and nucleus. These results suggested that separate Fe±S cluster assembly complexes could exist in different compartments of the cell (Land and Rouault, 1998) .
Here, we report cloning of a second human Fe±S cluster assembly enzyme, IscU. Preliminary biochemical studies showed that human IscU protein binds iron and can facilitate Fe±S cluster assembly in IRP1 (W.-H.Tong and T.Rouault, unpublished data), indicating that human IscU proteins are functional homologs of the bacterial and yeast IscU proteins. Analyses of genomic DNA, transcripts and translation products indicate that alternative splicing of iscU leads to expression of two iscU proteins that contain different subcellular targeting information. In accordance with the results on human IscS, the present study demonstrated that human IscU proteins are present in the cytosol as well as in the mitochondria. Furthermore, the co-immunoprecipitation experiments clearly indicate that mitochondrial IscU2 associates with the mitochondrial form of IscS, whereas IscU1 in the cytosol associates with the cytosolic form of IscS. These data therefore imply that separate Fe±S cluster assembly complexes are present in the mitochondria and in the cytosol in higher eukaryotes.
It is interesting to note that in the case of both human iscS and iscU, the mechanism of generating multiple isoforms from a single gene ensures that the proteins differ only at the N-terminus, while the functional portions of the proteins remain identical. In the case of the IscS protein, generation of multiple isoforms is mediated by differential utilization of in-frame AUGs of a single transcript (Land and Rouault, 1998) , whereas in the case of IscU, generation of the multiple isoforms is achieved by alternative splicing. The use of a single gene to generate distinct isoforms for different subcellular compartments may Compartmentalization of iron±sulfur cluster assembly enable cells to synchronize Fe±S cluster assembly in different compartments in the cell. Previous studies have shown that lowering the pH of the culture media results in an increase in synthesis of the mitochondrial IscS, accompanied by a proportional decrease in the cytosolic/ nuclear forms (Land and Rouault, 1998) . These results suggest that cells may vary the ratio of mitochondrial and cytosolic/nuclear IscS in accordance with changes in metabolic status. It will be interesting to see how expression of the two IscU isoforms is affected by variation in pH and iron availability.
Although distinct IscS and IscU complexes have been identi®ed in the cytosol and in the mitochondria in human cells, IscU and IscS in yeast have previously been detected only in the mitochondria (Garland et al., 1999; Kispal et al., 1999; Li et al., 1999; Schilke et al., 1999) . It has been proposed that mitochondria are the only site of Fe±S synthesis in yeast and that fully formed Fe±S clusters are exported from mitochondrial matrix for use in the cytosol (Kispal et al., 1999) . However, recent studies of IscA, another member of the isc operon in S.cerevisiae, have shown that IscA1 is in the mitochondrial matrix, whereas IscA2 is in the intermembrane space (Jensen and Culotta, 2000) , suggesting that yeast might also require isc gene products both inside and outside of the mitochondrial matrix.
Likewise, it is interesting to note that a signi®cant amount of IscU1 localizes to the nucleus when transiently expressed in COS-7 cells ( Figure 3A) . Preliminary western blot analysis revealed that endogenous IscU1 (p15) is also present in the nuclear fraction of RD4 cells (data not shown), suggesting that Fe±S cluster assembly also takes place in the nucleus. Although the sequence of IscU1 does not contain a recognizable nuclear localization signal, previous immuno¯uoresence and western blot analyses have shown that human IscS, which contains a nuclear localization motif, is also present in the nucleus (Land and Rouault, 1998) . It is therefore tempting to speculate that IscU1 is targeted to the nucleus by association with IscS. The potential requirement for Fe±S cluster assembly machinery in the nucleus is underscored by recent identi®cation of nuclear proteins that contain Fe±S binding motifs. Ntg2p (also known as Scr2) in S.cerevisiae is a functional homolog of an E.coli Fe±S protein, endonuclease III (You et al., 1998) . Spectroscopic studies of puri®ed Ntg2p showed that Ntg2p also possesses an Fe±S cluster (You et al., 1998) and¯uorescence microscopy revealed that an Ntg2p±green¯uorescent protein (GFP) fusion protein localizes to the nucleus (You et al., 1999) . Furthermore, a human homolog of Ntg2p, hNth1, has been shown to localize to both the mitochondria and the nucleus when transiently expressed in COS-7 or HeLa cells (Takao et al., 1998 ). An objective of future work will be to determine whether the Fe±S cluster assembly complex is also present in the nucleus and to address the possible biological signi®cance of nuclear Fe±S cluster assembly.
Intracellular iron homeostasis
The fact that iron accumulates in mitochondria in yeast strains with IscU mutations (Garland et al., 1999; Schilke et al., 1999) raises the question of what additional roles these gene products may play in mitochondrial and cytosolic iron homeostasis. The mechanisms by which iron is transported to target apoproteins in different subcellular compartments are unknown. Based on the recent advances of intracellular copper transport, it is possible that similar mechanisms exist for the intracellular transport of iron. In yeast, intracellular copper traf®cking involves the action of a family of low molecular weight, soluble, copper-binding proteins referred to as copper chaperones. These proteins bind copper ions and transport them to various cellular destinations, including cytochrome oxidase in the mitochondria (Glerum et al., 1996) , superoxide dismutase SOD1 in the cytosol and copper transporter Ccc2p in the secretory pathway (Lin et al., 1997) . It is conceivable that intracellular traf®cking of other biologically active trace metals such as iron is mediated through the action of another family of metal chaperones. In this respect, IscU may be part of a network of iron-traf®cking genes required for delivery of Fe to IRP1 in the cytosol and to various Fe±S proteins in the mitochondria. As copper chaperone proteins are thought to protect cells against copper toxicity by sequestering excess free copper (Pufahl et al., 1997) , iron chaperones' could potentially protect cells against iron toxicity. In the cytosol of mammalian cells, protection from the harmful effects of free iron is in large measure accomplished by sequestration of excess iron by ferritin. In mitochondria, however, iron-sequestration proteins have not been identi®ed thus far. Iron-binding proteins such as mitochondrial IscU may possibly serve to sequester free iron in the mitochondria and thus protect mitochondrial components against iron toxicity. Alternatively, mitochondrial IscU may be important in delivering excess free iron to unidenti®ed iron-sequestration proteins in the mitochondrial matrix.
The biochemical complexity of Fe±S cluster assembly in vivo is re¯ected in the number and organization of genes involved, as demonstrated by studies in A.vinelandii and S.cerevisiae. Dean and co-workers identi®ed an iscSUA±hscBA±fdx gene cluster in both A.vinelandii and E.coli (Zheng et al., 1998) . The co-expression of iscSUA genes with chaperone genes hscBA suggested the presence of a multiprotein complex for assembly and insertion of Fe±S clusters. The co-immunoprecipitation of human IscU and IscS proteins reported here provides further support for this idea. The demonstration of a stable IscU±IscS protein complex also raises the possibility of identifying other associated proteins by similar methods. In particular, a human IscA homolog has also been identi®ed based on sequence homology. Multiple tissue northern blot analysis indicated remarkably similar tissue distribution between human iscU, iscS and iscA ( Figure 2C ), suggesting a common role for these genes. Identi®cation of other proteins in the complex will allow characterization of Fe±S cluster assembly in vivo and further dissection of the factors that regulate cellular and mitochondrial iron homeostasis.
Materials and methods
Cloning and sequence analysis of human iscU homolog Clones containing sequences similar to bacterial nifU were obtained from the human EST database and analyzed by sequencing. To complete the cDNA sequences, 5¢ RACE (Clontech SMART PCR cDNA synthesis) were carried out using human heart (or liver) poly(A) + RNA. The 5¢ RACE ampli®cation products were cloned into Bluescript vector pSK + (Stratagene) or pNoTA/T7 vector (Eppendorf-5 Prime) and sequenced. Mapping of the intron±exon boundaries was carried out on the genomic sequence obtained by PCR (Advantage cDNA PCR).
Southern and northern blot analysis RACE ampli®cation products were separated on 1.5% agarose± formaldehyde gels and transferred to GeneScreen (Dupont NEN). 32 P-labeled DNA probes were prepared using the Megaprime DNA labeling system (Amersham) and hybridizations were carried out in Hybrisol (Oncor). For northern blot analysis, poly(A) + RNA from human heart (Clontech) and RD4 cells was separated on 1.5% agarose± formaldehyde gels, transferred to GeneScreen and hybridized to human iscU probes.
Antibody production
Synthetic multiple antigenic peptide (MAP) corresponding to amino acids 74±91 and 110±124 of human IscU2 was synthesized by Bio-Synthesis, Inc. Rabbit polyclonal antibodies 2934 and 2677 were generated by Covance Laboratories Inc. (Vienna, VA). Antibody to human IscS was generated as described previously (Land and Rouault, 1998) . Immunoaf®nity puri®cation of antisera was carried out using peptides immobilized on CNBr-activated Sepharose 4B (Pharmacia).
Cell culture, expression vectors and DNA transfection RD4 and COS cells were grown in Dulbecco's modi®ed Eagle's medium supplemented with 9% fetal calf serum, 100 U/ml penicillin, 100 U/ml streptomycin and 2 mM L-glutamine (DMEM-complete medium). Human iscU1 and iscU2 cDNAs were subcloned into pSX vector for COS cell transfections. Constructs encoding IscU1 contain 150 bp 5¢ of AUG2 and the complete iscU1 ORF sequence. Constructs encoding IscU2 contain 10 bp 5¢ of AUG1 and the complete iscU2 ORF sequence.
In some experiments, a myc epitope tag (MEQKLISEEDLN) or an HA tag (CYPYDVPDYASL) was added to the C-termini of the IscU constructs. Transfections were carried out by electroporation of COS cells with 10 mg of DNA (four pulses of 0.5 kV 3 99 ms; BTX Electrosquare porator model T820) and incubation for 48 h before immuno¯uorescence or metabolic labeling experiments.
Immuno¯uorescence
Transfected COS cells were ®xed in 2% paraformaldehyde at room temperature for 20 min, permeabilized with methanol for 2 min, and stained with a monoclonal anti-myc or a monoclonal anti-HA antibody (Babco), followed by¯uorescein-conjugated donkey antibodies to mouse IgG. The samples were photographed by immuno¯uorescence and phase contrast microscopy as described.
Metabolic labeling experiments
Transfected COS cells were incubated at 37°C for 30 min in methioninefree DMEM-complete medium (depletion medium). Pulse labelings were carried out at 37°C in depletion medium supplemented with 2 mCi/ml [ 35 S]methionine (ICN). At the end of the labeling interval, cells were washed once in chase medium (DMEM-complete medium supplemented with 5 mM methionine) at 4°C, then incubated in chase medium at 37°C for the appropriate intervals. At the end of the chase intervals, cells were washed four times with phosphate-buffered saline (PBS) before analysis.
RD4 cells were incubated at 37°C for 30 min in depletion medium, and then labeled at 37°C for 2 h in depletion medium supplemented with 2 mCi/ml [ 35 S]methionine.
Cell lysis and fractionation
For RD4 Triton lysates, cells were washed with ice-cold PBS and lysed in Triton X-100 lysis buffer (Land and Rouault, 1998) . For subcellular fractionation, cell pellets were suspended in digitonin lysis buffer [0.08% digitonin, 210 mM mannitol, 70 mM sucrose, 4 mM HEPES pH 7.2, 1 mM AEBSF (ICN), 0.5 mg/ml leupeptin]. The lysates were centrifuged at 600 g for 10 min at 4°C. The supernatants were centrifuged at 7000 g for 9 min at 4°C. The pellets were washed and lysed with Triton X-100 lysis buffer and considered as the membrane organelle fraction. The supernatants were centrifuged at 14 000 g for 10 min at 4°C, and the ®nal supernatants were considered as the cytosolic fraction.
Immunoprecipitation and western blotting Protein A±Sepharose beads with pre-absorbed antibodies (prepared by tumbling at 4°C for 1 h in lysis buffer) were added to cell lysates or fractions, and the mixture was tumbled at 4°C for 1±2 h. The beads were washed four times with cold lysis buffer, once with PBS and then incubated in elution buffer (1% SDS, 0.1 M Tris±HCl pH 7.4, 10 mM DTT) for 5 min at room temperature, 5 min at 65°C and 5 min at 95°C to elute bound proteins. The eluate was diluted 10-fold with lysis buffer supplemented with 0.1% (w/v) bovine serum albumin and 10 mM iodoacetic acid, and then used for a second immunoprecipitation. Lysates or immunoprecipitates were analyzed on SDS±polyacrylamide gels, followed by autoradiography or phosphoimaging analysis.
For western blot analysis, samples were separated by SDS± polyacrylamide gels and transferred to nitrocellulose. Blots were incubated in antibody diluted in blocking buffer (5% non-fat dry milk, 0.1% Triton X-100, PBS) for 1±2 h at room temperature. Horseradish peroxidase-conjugated secondary antibodies were detected by an ECL system (Pierce).
DDBJ/EMBL/GenBank accession numbers
The DDBJ/EMBL/GenBank accession numbers for IscU1 and IscU2 are AY009127 and AY009128, respectively.
